Canada - Tiếng Anh - Health Canada

sanis health inc - valproic acid (divalproex sodium) - tablet (enteric-coated) - 500mg - valproic acid (divalproex sodium) 500mg - miscellaneous anticonvulsants

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

remedyrepack inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 100 mg

Canada - Tiếng Anh - Health Canada

actavis pharma company - irbesartan - tablet - 75mg - irbesartan 75mg - angiotensin ii receptor antagonists

Canada - Tiếng Anh - Health Canada

actavis pharma company - irbesartan - tablet - 150mg - irbesartan 150mg - angiotensin ii receptor antagonists

Canada - Tiếng Anh - Health Canada

actavis pharma company - irbesartan - tablet - 300mg - irbesartan 300mg - angiotensin ii receptor antagonists

Canada - Tiếng Anh - Health Canada

amylyx pharmaceuticals inc. - sodium phenylbutyrate; ursodoxicoltaurine - powder for suspension - 3g; 1g - sodium phenylbutyrate 3g; ursodoxicoltaurine 1g

Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

angelini pharma s.p.a - cenobamate - epilepsy - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Canada - Tiếng Anh - Health Canada

insite vision incorporated - azithromycin - solution - 1% - azithromycin 1% - antibacterials

Canada - Tiếng Anh - Health Canada

inspire pharmaceuticals inc - azithromycin - solution - 1% - azithromycin 1% - antibacterials

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

citron pharma llc - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 25 mg - topiramate tablets are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures. safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials [see clinical studies (14.1)] . topiramate tablets are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with lennox-gastaut syndrome [see clinical studies (14.2)] . topiramate tablets are indicated for adults for the prophylaxis of migraine headache [see clinical studies (14.3)]. the usefulness of topiramate tablets in the acute treatment of migraine headache has not been studied. additional pediatric use information for patients ages 12 to 17 years is approved for janssen pharmaceuticals, inc.’s topamax (t